Alere to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis & Expand Manufacturing for POC HIV Viral Load Platform WALTHAM, Mass., March 1, 2013 /PRNewswire/ -- Alere Inc.

The $21.6 million grant will fund the development of a tuberculosis assay, which will be designed for use in both resource-constrained and well-resourced settings. It will also support the company’s ...

A simple blood test that accurately diagnoses active tuberculosis could save hundreds of thousands of lives each year, experts said today. The test makes it easier and cheaper to control the disease, ...

WALTHAM, Mass., March 1, 2013 /PRNewswire/ -- Alere Inc. announced today that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill & Melinda Gates ...